B. de Jong

Recent Advances in Extracellular Vesicles as Drug Delivery Systems and Their Potential in Precision Medicine

J. Hoenderop, J. P. Rigalli, B. de Jong, 2020, Pharmaceutics.

Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism

P. Parren, R. G. Hibbert, A. Lingnau, 2020, Molecular Cancer Therapeutics.

A human kidney and liver organoid‐based multi‐organ‐on‐a‐chip model to study the therapeutic effects and biodistribution of mesenchymal stromal cell‐derived extracellular vesicles

B. W. van Balkom, M. Verhaar, L. J. van der Laan, 2022, Journal of extracellular vesicles.

DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing

P. Parren, S. Verploegen, A. Labrijn, 2020, EBioMedicine.

Logic-gated antibody pairs that selectively act on cells co-expressing two antigens

M. Wester, S. Verploegen, D. Lidke, 2022, Nature Biotechnology.